Relato de caso fatal por doença linfoproliferativa monomórfica disseminada pós transplante descoberto na necropsia
DOI:
https://doi.org/10.34119/bjhrv7n2-381Keywords:
doença linfoproliferativa pós transplante, imunossupressão, transplante renal, vírus Epstein-BarrAbstract
Trata-se de uma entidade nosológica, que compromete o paciente transplantado renal, sob uso de imunossupressores e infectado pelo EBV, este por último participa da patogênese através da proliferação de linfócitos tipo B clonal neoplásico, que envolve de forma disseminada, causando uma verdadeira embolia endovascular e infiltração intersticial de vários órgãos inclusive cérebro, culminando em déficit neurológico focal, criando uma vasta gama de diagnósticos diferenciais que responde à terapia inicialmente empregada.
References
BITENCOURT, Almir Galvão Vieira et al . Incidência e aspectos de imagem do linfoma pós-transplante hepático em crianças. Radiol Bras, São Paulo , v. 45, n. 1, p. 7-11, Feb. 2012. Available from <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100- 39842012000100004&lng=en&nrm=iso>.access
on 18 Aug. 2019. http://dx.doi.org/10.1590/S0100-39842012000100004.
Zafar SY, Howell DN, Gockerman JP. Malignancy after solid organ transplantation: an overview. Oncologist. 2008;13:769-78.
Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol. 2005;56:155-67.
Kamdar KY, Rooney CM, Heslop HE. Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant. 2011;16(3):274-80.
Saha A, Robertson ES. EpsteinBarr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clinical cancer research: an official journal of the American Association for Cancer Research. 2011;17(10):3056-63.
Stevens, S. (2001). Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 97(5):1165-1171.
Holman, C., Karger, A., Mullan, B., Brundage, R., & Balfour, H. (2012). Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder. Clinical Transplantation 26(5):741-747.
US Multicenter FK 506 Liver Study Goup. Use os Prograf (FK 506) as Rescue therapy for refractory rejection after liver transplatation. Transplant Proc 1993;25:679-88. US Multicenter Liver Study Group. Efficacy os tacrolimus as rescue therapy for chronic in orthotopic liver trnasplatation. Transplantation 1997;64:2558-63. Peter D, Fitton A, PLasker G, Faulds D, Tracolimus. Drugs 1993;46:746-94. Morris RE. Mechanisms os action of new immunosupressive drugs. Kidney Int 1996;49(suppl 53):26:38. J Bras Nefrol 2000;22(2):114-20.
Wijdicks EFM, Wiesner RH, Dahlke LJ, Krom RAF. Neurotoxicidade induzida por FK 506 no transplante de fígado. Ann Neurol 1994 ; 35 : 4 98-501.PubMed.
Estol CJ, Pessin MS, Martinez AJ. Complicações cerebrovasculares após transplante hepático ortotópico: um estudo clínico-patológico.Neurology 1991 ; 41 : 8 15-819.
Small SL, Fukui MB, Bramblett GT, Eidelman BH. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK 506).Ann Neurol 1996;40:575-580. CrossRefPubMed.
G. P. Pizzolato, R. Sztajzel, K. Burkhardt, M. Megret, B. Borisch. Cerebral vasculitis during FK 506 treatment in a liver transplant patient. First published April 1, 1998, DOI: https://doi.org/10.1212/WNL.50.4.1154
WHO- Classification of Tumors of- Haematopietic Lymphoid Tissues. 4thed., Post –
Transplant lymphoproliferative disorders. pag. 453.
David Dabbs, ed.- Diagnostic Immunohitochesmistry 3th Ed., Saunders 2010.
